Biotech

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 16.10.2023.

Pharmaceutical drug
National University of Singapore
Health
United States
Human
Organism

@WSJ Health shared
On Oct 15, 2023
Fake tweet - https://futurism.com/neoscope/monkey-lives-two-years-pig-kidney
Open
Monkey Lives for Two Years With Gene-Hacked Pig Kidney

Monkey Lives for Two Years With Gene-Hacked Pig Kidney

The pig was actually a miniature pig, which was engineered with nearly 70 gene edits, including the addition of human DNA.

@WSJ Health shared
On Oct 12, 2023
Fake tweet - https://www.forbes.com/sites/mattsymonds/2023/10/11/the-business-schools-looking-to-fix-healthcare/
Open
The Business Schools Looking To Fix Healthcare

The Business Schools Looking To Fix Healthcare

Business schools are tackling some of the world’s greatest challenges, and healthcare is high on the list.

@WSJ Health shared
On Oct 12, 2023
Fake tweet - https://news.sky.com/story/extraordinary-milestone-as-monkey-with-pigs-kidney-lives-for-two-years-12982489
Open
'Extraordinary milestone' as monkey with pig's kidney lives for two years

'Extraordinary milestone' as monkey with pig's kidney lives for two years

In the UK alone, more than 5,000 people are waiting for a kidney - the study gives extra encouragement that humans could one day live long-term with a modified animal organ.

@WSJ Health shared
On Oct 14, 2023
Fake tweet - https://www.smithsonianmag.com/innovation/new-synthetic-horseshoe-crab-blood-could-mean-pharma-wont-bleed-the-species-dry-180983054/
Open
New Synthetic Horseshoe Crab Blood Could Mean Pharma Won’t Bleed the Species Dry

New Synthetic Horseshoe Crab Blood Could Mean Pharma Won’t Bleed the Species Dry

The “living fossils” have been vital for testing intravenous drugs, but a few large pharmaceutical companies are using a lab-made compound instead

@WSJ Health shared
On Oct 13, 2023
Fake tweet - https://phys.org/news/2023-10-synthetic-horseshoe-crab-blood-alternatives.html
Open
New synthetic horseshoe crab blood alternatives could mean pharma won't bleed this unique species dry

New synthetic horseshoe crab blood alternatives could mean pharma won't bleed this unique species dry

If you have ever gotten a vaccine or received an intravenous drug and did not come down with a potentially life-threatening fever, you can thank a horseshoe crab (Limulus polyphemus).

@WSJ Health shared
On Oct 13, 2023
Fake tweet - https://fortune.com/2023/10/12/pfizer-ceo-albert-bourla-tap-china-science-cancer-treatment-covid-vaccine/
Open
Pfizer CEO Albert Bourla wants to tap ‘Chinese science’ as the drug company looks for a new target after COVID

Pfizer CEO Albert Bourla wants to tap ‘Chinese science’ as the drug company looks for a new target after COVID

Bourla hopes to bring the same speed in developing a COVID vaccine to discovering new cancer treatments.

@WSJ Health shared
On Oct 13, 2023
Fake tweet - https://theconversation.com/horseshoe-crab-blood-is-vital-for-testing-intravenous-drugs-but-new-synthetic-alternatives-could-mean-pharma-wont-bleed-this-unique-species-dry-214622
Open
Horseshoe crab blood is vital for testing intravenous drugs, but new synthetic alternatives could mean pharma won’t bleed this unique species dry

Horseshoe crab blood is vital for testing intravenous drugs, but new synthetic alternatives could mean pharma won’t bleed this unique species dry

Horseshoe crabs play a unique role in medicine, but they’re also ecologically important in their home waters along the Atlantic coast. Can regulators balance the needs of humans and nature?

@WSJ Health shared
On Oct 13, 2023
Fake tweet - https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0292653
Open
Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease

Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease

Coronary artery lesions (CALs) are the most common and serious complication of Kawasaki disease (KD), and the pathogenesis is unknown. Exploring KD-specific biomarkers and related risk ...